May 30, 2019
Dr Jonathan Brotchie will attend the Gordon Research Conference on Cannabinoid Function in the CNS on 21st-26th July in Barcelona, Spain. Abide Therapeutics and Atuka will present a poster entitled “The selective monoacylglycerol lipase inhibitor ABD-101970 reduces L-DOPA-induced dyskinesia in MPTP-lesioned macaques” at the meeting.
More information on the conference can be found here
Description & References:
Product Spec:
CAS No.:
Molecular Structure: